The three-year grant to Korean chemical company LG Chem will be used to advance clinical trials on a new inactivated polio vaccine....
NYS Entity Status
NYS Filing Date
JULY 15, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2014 - ADVANCED CLINICAL EDUCATION FOUNDATION OF THE NEW YORK STATE SOCIETY FOR CLINICAL SOCIAL WORK, INC.
AROUND THE WEB
- Gates Foundation Awards $12.6 Million for Polio Vaccine Research
By email@example.com (Matt Sinclair) - Sunday Jun 11, 2017
- Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists
By Corie Lok - Monday Aug 28, 2017
It’s clear at this point that patients are no longer just subjects in clinical trials. Thanks to the growing power of patient advocacy groups—and an FDA eager to hear their perspective—patients and drug developers are increasingly finding creating ways to work together, as we’ve seen with the four finalists in the Patient Partnership category of […]
- Cleveland Clinic Receives $10 Million for Expansion of Eye Institute
By firstname.lastname@example.org (Mitch Nauffts) - Monday Jun 5, 2017
The gift from the Timken Foundation of Canton will support an expansion of the Cole Eye Institute and the creation of the Louise Timken Ophthalmic Education Center....
- Rutgers Receives $4 Million for Cancer Research Partnership
By email@example.com (Kyoko Uchida) - Wednesday Aug 23, 2017
The grants, which include $2 million from the Robert Wood Johnson Foundation, will enable RCI and the Center for Cancer Research to share knowledge and more rapidly advance discoveries leading to drug development, clinical trials, and new therapies for cancer patients....
- Bio Roundup: ASCO Digested, Juliet Unveiled, PTC Slated & More
By Alex Lash - Friday Jun 9, 2017
The New York Times Magazine wrote a few weeks ago about the extraordinary metabolic changes in a python after it gulps down a 50,000 calorie meal. The biomedical world was like a postprandial python this week; after extending its maw around the supersized meal of news and data from the American Society for Clinical Oncology […]
- FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths
By Frank Vinluan - Wednesday Jul 5, 2017
Nearly a month after Merck paused enrollment in three clinical trials in multiple myeloma to gather more information about patient deaths, the FDA has now put a stop to those studies altogether. Merck (NYSE: MRK) said Wednesday that the FDA has placed a complete hold on two Phase 3 trials testing its immunotherapy drug pembrolizumab […]